Cd Diagnostics, Inc is categorized under Biotechnology Products and Services in Wynnewood, PA and active since 2008.
Cd Diagnostics, Inc was established in 2008, and today employs 1 to 4, earning Unknown per year. This is a Biotechnology Products and Services business, which does work in the B2B market, and is classified as a Biotechnology Products and Services, under code number by the NAICS.
If you are seeking more information, feel free to contact Stephanie Serafino at the company’s headquarters by writing to 100 E Lancaster Avenue
LIMR Suite R215, Wynnewood, Pennsylvania PA 19096 or by phoning (484) 476-4800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cd Diagnostics, Inc |
| Contact Person: | Stephanie Serafino |
| Address: | 100 E Lancaster Avenue LIMR Suite R215, Wynnewood, Pennsylvania 19096 |
| Phone Number: | (484) 476-4800 |
| Website Address: | cddiagnostics.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2008 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biotechnology Products and Services |
| Share This Business: |
Cd Diagnostics, Inc was started in 2008 to provide professional Biotechnology Products and Services under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Stephanie Serafino for inquiries that concern Cd Diagnostics, Inc by calling the company number (484) 476-4800, as your correspondence is most welcome.
Additionally, the physical location of the headquarters of Cd Diagnostics, Inc can be found at the coordinates 39.98975,-75.31561 as well as the street address 100 E Lancaster Avenue
LIMR Suite R215 in Wynnewood, Pennsylvania 19096.
For its online presence, you may visit Cd Diagnostics, Inc’s website at cddiagnostics.com and engage with its social media outlets through on Twitter and on Facebook.